Description

Oxaliplatin Concentrate for Infusions 5 mg/ml. 40 ml. (200 mg.) №1

Ingredients:

Each ml contains 5 mg of oxaliplatin as the active ingredient. Other ingredients include lactose monohydrate, water for injections, and hydrochloric acid for pH adjustment.

Dosage:

The recommended dosage of Oxaliplatin concentrate for infusions is determined by the patient’s body surface area and health condition. It is administered intravenously over a specific period as directed by a healthcare professional.

Indications:

Oxaliplatin is indicated for the treatment of advanced colorectal cancer. It is often used in combination with other chemotherapy medications.

Contraindications:

This medication is contraindicated in patients with known hypersensitivity to oxaliplatin or any of the ingredients in the formulation. It should not be used in patients with pre-existing renal impairment.

Directions:

Oxaliplatin should only be administered by healthcare professionals experienced in the use of chemotherapy medications. The infusion should be given in a controlled clinical setting with appropriate monitoring.

Scientific Evidence:

Oxaliplatin is a platinum-based chemotherapy drug that works by interfering with the DNA in cancer cells, ultimately leading to cell death. Studies have shown its efficacy in improving survival rates and reducing tumor size in patients with advanced colorectal cancer.

Clinical trials have demonstrated that Oxaliplatin, when used in combination with other chemotherapy agents, can significantly increase progression-free survival and overall response rates compared to traditional treatment regimens.